5 | CONCLUSION
AHPV-GT testing in conjunction with age stratification may be a suitable
prognostic method for women with histologic LSIL (CIN1) preceded by
AHPV-positive/normal or mildly abnormal cytology. Immediate treatment is
a rational recommendation for women ≥ 25 years old with histologic LSIL
(CIN1) preceded by AHPV-GT positivity when good surveillance is not
assured.